Searchable abstracts of presentations at key conferences in endocrinology

ea0011p40 | Bone | ECE2006

Does parathyroidectomy reduce the risk of fractures and renal stones? Results of a systematic review and meta analysis

Sanders BE , Davies M , Selby PL

Primary hyperparathyroidism (PHP) is a common endocrine condition. The associated metabolic abnormalities are usually amenable to surgical treatment (PTX). Although it is generally believed that such treatment will reduce the risk of long-term complications this has not been demonstrated in a clinical trial and the current treatment guidelines are based on consensus. In order to assess the effect of parathyroidectomy on two of the most common complications of PHP, renal stones...

ea0012oc15 | Placenta, bone and genetics | SFE2006

Preliminary results from the PRISM study: a multicentre randomised controlled trial of intensive vs. symptomatic management for Paget’s disease of bone

Ralston SH , Langston AL , Campbell MK , MacLennan G , Selby PL , Fraser WD

Bisphosphonates are the treatment of choice for Paget’s disease of bone (PDB). However, long-term effects on complications are unknown. The PRISM trial was a randomised controlled trial comparing symptomatic management and intensive bisphosphonate therapy for PDB, and involved 1324 patients followed for a median of 32 months (range 12–48). Patients allocated to symptomatic therapy (n=663) were untreated unless they had bone pain, at which point they received a...